Navigation Links
PET can help guide treatment decisions for a common pediatric cancer
Date:8/3/2009

RESTON, Va.A new study published in the August issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) is an important tool for depicting the extent of neuroblastoma in some patients, particularly for those in the early stages of the disease. Neuroblastoma accounts for six to ten percent of all childhood cancers in the United States and 15 percent of cancer deaths in children. Accurately identifying where in the body the disease is located and whether it is spreading is critical for choosing appropriate types of treatment, which can include surgery, chemotherapy, radiation andin the most advanced casesa combination of all of these treatments along with bone marrow transplant or investigational therapies.

In recent years, 123I-metaiodobenzylguanidine (MIBG) has been the main functional imaging agent used to assess the disease. Fluorodeoxyglucose (FDG) PET imaging of neuroblastoma is increasing, but questions remain regarding when and in which patients FDG PET imaging is most useful.

"Functional imaging plays an important role in assessing neuroblastoma, from initially diagnosing and staging the disease to determining whether patients are responding to treatment or whether the disease has recurred," said Susan E. Sharp, M.D., assistant professor of clinical radiology at Cincinnati Children's Hospital Medical Center and lead author of the study. "Our study found that while MIBG remains the front-line imaging tool for neuroblastoma, FDG-PET imaging can benefit some patients, especially those with early-stage disease."

The study also found that FDG PET may also be useful in imaging neuroblastoma tumors that do not readily absorb MIBG. In these cases, imaging with MIBG alone may not reveal some malignant lesions in the body.

Neuroblastomaa form of cancer that starts in certain types of very primitive developing nerve cells found in an embryo or fetusoccurs most frequently in infants and young children. There are about 650 new cases of the cancer reported in the U.S. each year, according to the National Cancer Institute. The cancer most often originates on the adrenal glandsthe triangular-shaped glands above the kidneys. Neuroblastoma often spreads to other parts of the body before any symptoms are apparent.

Patients with the disease are classified as low-, medium- or high-risk based on a combination of clinical staging of the disease and certain biologic and genetic characteristics, such as the age of the patient, extent of disease spread, microscopic appearance and genetic factors.

Treatment for each of the risk categories is very different. If the cancer is limited to one part of the body, it is often curable with surgery, sometimes with the addition of chemotherapy. However, long-term survival for children older than 18 months of age with advanced disease is poor despite aggressive treatments that include a combination of chemotherapy, surgery, bone marrow transplant and investigational therapies.

In the study, a total of 113 paired MIBG scans and FDG PET scans in 60 patients with neuroblastoma at two major pediatric cancer institutions were reviewed. PET was used in conjunction with localization computerized tomography (CT) scans, and MIBG planar and SPECT imaging were combined. The study shows that for stage 1 and stage 2 neuroblastoma patients, FDG-PET depicted more primary or residual neuroblastoma, although MIBG imaging may be needed to exclude higher-stage disease that has spread to the bone or bone marrow. MIBG is superior in evaluating stage 4 neuroblastoma, primarily because it can detect and follow the response to treatment of tumor in the bone or bone marrow more accurately.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. The San Francisco SPCA Launches Online Guide for Summer Pet Health & Safety
2. New Spanish-Language Consumer Guides Compare Treatments for Depression, Prostate Cancer and Other Conditions
3. New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians
4. American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fractures
5. American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures
6. The Boston Funeral Guide Is Live
7. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
8. New: Interventional radiology coding users guide
9. Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines(R) for Medicare, Medicaid Reviews
10. CareGuide Adds New Management Team Members
11. Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... “Beyond and Back”: a true-life ... is the creation of published author Bonetta Rose, a wife, mother and grandmother committed ... Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual events in the ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... the existence of God. “A Respectful Response To Atheist Manifesto” is the creation ... married to his wife, Nancy, for sixty years. He holds graduate degrees from ...
(Date:3/22/2017)... ... 23, 2017 , ... Death anxiety is unconscious and needs understanding and non-judgmental ... inspired to write the book titled “ As Good as Goodbyes Get ” (published ... of what she was experiencing at the bedside of patients who were dying. The ...
(Date:3/22/2017)... San Jose, CA (PRWEB) , ... March 22, ... ... of San Jose, Santa Cruz and Milpitas with a robust, ongoing community enrichment ... Supportive Housing (FSH), a nonprofit organization which has provided for the critical needs ...
(Date:3/22/2017)... Ramon, CA (PRWEB) , ... March 22, 2017 ... ... tissue recovery agency for northern California and Nevada and LABS, Inc., announced the ... rapid turnaround (STAT) infectious disease screening and serology testing used to determine ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... 2017 Ampio Pharmaceuticals, Inc. (NYSE MKT: ... a low molecular weight fraction of human serum ... is re-issuing its previous release that was made on ... are required under the NYSE MKT Company Guide ... disclosures along with the previously disclosed update of ...
(Date:3/22/2017)... 22, 2017 New Jersey,s ... patient harm and saved $641 million in healthcare costs ... a national quality improvement program. The ... Patients-New Jersey, part of a national initiative from the ... the New Jersey Hospital Association and its affiliate, the ...
(Date:3/22/2017)...  Ablation is the minimally invasive therapeutic tissue ... purposes, from cancerous or diseased tissue removal, to ... atrial fibrillation and others. The growing adoption of ... innovate and improvise existing ablation technologies for better ... market is expected to grow at high single ...
Breaking Medicine Technology: